IMMUNOTOXICITY
Clinical trials for IMMUNOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOTOXICITY trials appear
Sign up with your email to follow new studies for IMMUNOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a daily walk tame Immunotherapy's harsh side effects?
Disease control Recruiting nowThis study explores whether being physically active can help melanoma patients avoid or lessen the immune-related side effects of immunotherapy drugs like pembrolizumab and nivolumab. Researchers will track the activity levels of 160 adults starting immunotherapy and monitor them…
Matched conditions: IMMUNOTOXICITY
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Scientists investigate why immunotherapy causes autoimmune problems in some cancer patients
Knowledge-focused Recruiting nowThis study aims to understand why some cancer patients develop autoimmune side effects when treated with immune checkpoint inhibitors. Researchers will analyze blood cells and genetics from 600 participants to identify features linked to these side effects. The goal is to improve…
Matched conditions: IMMUNOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC